Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search span> per sponsor: PIERRE FABRE MEDICAMENT (Represented by: Institut de Recherche Pierre Fabre)
Woman and Man Max 99 years
PIERRE FABRE MEDICAMENT (Represented by: Institut de Recherche Pierre Fabre)
Update Il y a 5 ans
A 4-week double-blind placebo-controlled pilot study, evaluating niacin-induced flushing and lipid parameter effects of V0002 CA 1g 3 capsules/day associated with Niaspan® (from 375 mg to 1000 mg) in addition to usual care statin, in patients suffering from dyslipidemia with uncontrolled elevated triglycerides
To assess efficacy of V0002 CA 1 g at 3 capsules /day on preventing niacin-induced flushing promoted by Niaspan® administration
Country
None
organs
None
Specialty
None
unknown
More information